Literature DB >> 20172129

EuroSCORE performance in valve surgery: a meta-analysis.

Alessandro Parolari1, Lorenzo L Pesce, Matteo Trezzi, Laura Cavallotti, Samer Kassem, Claudia Loardi, Davide Pacini, Elena Tremoli, Francesco Alamanni.   

Abstract

BACKGROUND: The European System for Cardiac Operative Risk Evaluation (EuroSCORE) was developed to predict immediate outcomes after adult cardiac operations, but less than 30% of the cases used to develop this score were valve procedures. We studied EuroSCORE performance in valve procedures.
METHODS: We performed a meta-analysis of published studies reporting the assessment of discriminatory power of the EuroSCORE by receiver operating characteristics (ROC) curve analysis in adult valve operations. A comparison of observed and predicted mortality rates was also performed.
RESULTS: A literature search identified 37 potentially eligible studies, and 12 were selected for meta-analysis comprising 26,621 patients with 1250 events (mortality rate, 4.7%). Meta-analysis of these studies provided an average area under the curve (AUC) value of 0.730 (95% confidence interval [CI], 0.717 to 0.743). The same results were obtained when meta-analyses were performed separately in studies categorized on reliability of uncertainty estimation: in the seven studies reporting reliable uncertainty estimation (8175 patients with 358 events; mortality rate, 4.4%), the ROC curve provided an average AUC value of 0.724 (95% CI, 0.699 to 0.749). The five studies not reporting reliable uncertainty estimation (18,446 patients with 892 events; mortality rate, 4.8%) had an average AUC of 0.732 (95% CI, 0.717 to 0.747). We documented a constant trend to overpredict mortality by EuroSCORE, both in the additive and especially in the logistic form.
CONCLUSIONS: The EuroSCORE has low discrimination ability for valve surgery, and it sensibly overpredicts risk. Alternative risk scoring algorithms should be seriously considered. 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20172129     DOI: 10.1016/j.athoracsur.2009.11.032

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  27 in total

1.  Transvascular transcatheter aortic valve implantation in 2017.

Authors:  Luise Gaede; Johannes Blumenstein; Christoph Liebetrau; Oliver Dörr; Won-Keun Kim; Holger Nef; Oliver Husser; Jan Gülker; Albrecht Elsässer; Christian W Hamm; Stephan Achenbach; Helge Möllmann
Journal:  Clin Res Cardiol       Date:  2019-06-24       Impact factor: 5.460

2.  Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair.

Authors:  Luise Gaede; Johannes Blumenstein; Won-Keun Kim; Christoph Liebetrau; Oliver Dörr; Holger Nef; Christian Hamm; Albrecht Elsässer; Helge Möllmann
Journal:  Clin Res Cardiol       Date:  2017-01-11       Impact factor: 5.460

3.  Cardiac operative risk evaluation: The EuroSCORE II, does it make a real difference?

Authors:  L Noyez; P C Kievit; H A van Swieten; M-J de Boer
Journal:  Neth Heart J       Date:  2012-12       Impact factor: 2.380

4.  New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.

Authors:  J Briolat; S D Wu; S K Mahata; B Gonthier; D Bagnard; S Chasserot-Golaz; K B Helle; D Aunis; M H Metz-Boutigue
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

5.  Temporal trends in transcatheter and surgical aortic valve replacement : An analysis of aortic valve replacements in Germany during 2012-2014.

Authors:  L Gaede; W-K Kim; J Blumenstein; C Liebetrau; O Dörr; H Nef; C Hamm; T Walther; S Achenbach; A Elsässer; H Möllmann
Journal:  Herz       Date:  2016-08-05       Impact factor: 1.443

Review 6.  [Interdisciplinary differential treatment of structural heart disease : When operation and when catheter-based intervention?].

Authors:  S Yücel; H Ince; S Kische; M A Sherif; H Bushnaq; A Bärisch; A Öner
Journal:  Herz       Date:  2016-08       Impact factor: 1.443

7.  [Prophylactic intraaortic balloon pumping in high-risk cardiac surgery patients].

Authors:  D Metz; M Stiller; R-E Silber; H Kroll; H-S Hofmann; C Diez
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-29       Impact factor: 0.840

8.  Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial).

Authors:  Nirat Beohar; Alan Zajarias; Vinod H Thourani; Howard C Herrmann; Michael Mack; Samir Kapadia; Philip Green; Suzanne V Arnold; David J Cohen; Philippe Généreux; Ke Xu; Martin B Leon; Ajay J Kirtane
Journal:  Am J Cardiol       Date:  2014-08-27       Impact factor: 2.778

9.  Comparison of contemporary risk scores for predicting outcomes after surgery for active infective endocarditis.

Authors:  Tom Kai Ming Wang; Timothy Oh; Jamie Voss; Greg Gamble; Nicholas Kang; James Pemberton
Journal:  Heart Vessels       Date:  2014-01-25       Impact factor: 2.037

Review 10.  Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based Analysis (part B).

Authors:  S Sehatzadeh; B Doble; F Xie; G Blackhouse; K Campbell; K Kaulback; K Chandra; R Goeree
Journal:  Ont Health Technol Assess Ser       Date:  2012-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.